JP2021503004A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503004A5
JP2021503004A5 JP2020544372A JP2020544372A JP2021503004A5 JP 2021503004 A5 JP2021503004 A5 JP 2021503004A5 JP 2020544372 A JP2020544372 A JP 2020544372A JP 2020544372 A JP2020544372 A JP 2020544372A JP 2021503004 A5 JP2021503004 A5 JP 2021503004A5
Authority
JP
Japan
Prior art keywords
isopropyl
indole
piperidine
pyridine
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020544372A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021503004A (ja
JP7265554B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/060590 external-priority patent/WO2019099336A1/en
Publication of JP2021503004A publication Critical patent/JP2021503004A/ja
Publication of JP2021503004A5 publication Critical patent/JP2021503004A5/ja
Application granted granted Critical
Publication of JP7265554B2 publication Critical patent/JP7265554B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020544372A 2017-11-14 2018-11-13 置換インドール化合物 Active JP7265554B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762585733P 2017-11-14 2017-11-14
US62/585,733 2017-11-14
PCT/US2018/060590 WO2019099336A1 (en) 2017-11-14 2018-11-13 Substituted indole compounds

Publications (3)

Publication Number Publication Date
JP2021503004A JP2021503004A (ja) 2021-02-04
JP2021503004A5 true JP2021503004A5 (https=) 2021-12-16
JP7265554B2 JP7265554B2 (ja) 2023-04-26

Family

ID=64565001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020544372A Active JP7265554B2 (ja) 2017-11-14 2018-11-13 置換インドール化合物

Country Status (7)

Country Link
US (2) US20210253593A1 (https=)
EP (1) EP3710440B1 (https=)
JP (1) JP7265554B2 (https=)
KR (1) KR102849449B1 (https=)
CN (1) CN111448190B (https=)
ES (1) ES2945435T3 (https=)
WO (1) WO2019099336A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BR112020012084A2 (pt) * 2017-12-19 2020-11-24 Bristol-Myers Squibb Company compostos de indol substituído úteis como inibidores de tlr
BR112020011984A2 (pt) * 2017-12-20 2020-11-17 Bristol-Myers Squibb Company compostos de amino indol úteis como inibidores de tlr
US11299501B2 (en) * 2017-12-20 2022-04-12 Bristol-Myers Squibb Company Diazaindole compounds
CA3085942A1 (en) * 2017-12-20 2019-06-27 Bristol-Myers Squibb Company Aryl and heteroaryl substituted indole compounds
JP7328977B2 (ja) 2018-02-12 2023-08-17 エフ. ホフマン-ラ ロシュ アーゲー ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
KR20210018818A (ko) 2018-06-05 2021-02-18 에프. 호프만-라 로슈 아게 자가면역 질환의 치료를 위한 테트라하이드로-1H-피라지노[2,1-a]이소인돌릴퀴놀린 화합물
EP3807270B1 (en) 2018-06-12 2023-09-13 F. Hoffmann-La Roche AG Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
US11952363B2 (en) 2018-07-23 2024-04-09 Hoffmann-La Roche Inc. Piperazine compounds for the treatment of autoimmune disease
WO2020048583A1 (en) 2018-09-04 2020-03-12 F. Hoffmann-La Roche Ag Benzothiazole compounds for the treatment of autoimmune diseases
WO2020048595A1 (en) 2018-09-06 2020-03-12 F. Hoffmann-La Roche Ag Novel cyclic amidine compounds for the treatment of autoimmune disease
JP7367004B2 (ja) 2018-09-06 2023-10-23 エフ. ホフマン-ラ ロシュ アーゲー 自己免疫疾患の処置のための新規のピラゾロビリジン化合物
CN112771047A (zh) * 2018-09-27 2021-05-07 重庆复创医药研究有限公司 作为RET激酶抑制剂的取代的咪唑[1,2-a]吡啶和[1,2,4]三唑[1,5-a]吡啶化合物
CN114829350B (zh) * 2019-10-04 2024-05-28 百时美施贵宝公司 经取代的咔唑化合物
US12421240B2 (en) 2019-10-31 2025-09-23 Hoffmann-La Roche Inc. Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease
JP2023502087A (ja) 2019-11-19 2023-01-20 エフ.ホフマン-ラ ロシュ アーゲー 自己免疫疾患の処置のためのヒドロ-1H-ピロロ[1,2-a]ピラジン化合物
JP7649306B2 (ja) 2019-11-20 2025-03-19 エフ. ホフマン-ラ ロシュ アーゲー 自己免疫疾患の処置のためのスピロ(イソベンゾフラナゼチジン)化合物
AU2021328577A1 (en) 2020-08-19 2023-03-23 Bristol-Myers Squibb Company 1H-pyrrolo[3,2-c]pyridine and 1H-pyrrolo[2,3-c]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
AR123286A1 (es) 2020-08-19 2022-11-16 Bristol Myers Squibb Co Compuestos de benzimidazol sustituidos útiles como inhibidores de tlr9
AR123281A1 (es) * 2020-08-19 2022-11-16 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos útiles como inhibidores de tlr9
ES3054393T3 (en) * 2021-02-09 2026-02-03 Gilead Sciences Inc Thienopyrrole compounds
CN116783202A (zh) * 2021-02-09 2023-09-19 吉利德科学公司 噻吩并吡咯化合物
KR20230171469A (ko) 2021-04-16 2023-12-20 길리애드 사이언시즈, 인코포레이티드 티에노피롤 화합물
WO2022238816A1 (en) * 2021-05-14 2022-11-17 Bm Pharma Consulting Pty. Ltd Bicyclic heterocyclic compounds for prophylaxis and treatment of viral infections
EP4398989A1 (en) 2021-09-10 2024-07-17 Gilead Sciences, Inc. Thienopyrrole compounds
JP2025508741A (ja) * 2022-02-18 2025-04-10 ブリストル-マイヤーズ スクイブ カンパニー Tlr9の阻害剤として有用な置換された二環ヘテロアリール化合物
CN114591339B (zh) * 2022-05-10 2022-08-02 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用
WO2024027712A1 (zh) * 2022-08-01 2024-02-08 索智生物科技(浙江)有限公司 含氮杂环类化合物、其制备方法及其应用
CN115417869B (zh) * 2022-09-19 2024-06-11 安徽大学 一种6-溴咪唑[1.2a]吡啶-3-甲酰胺的合成方法
ES2993583B2 (es) 2023-06-27 2025-09-22 Univ Valencia Derivados de imidazo[1,2-a]piridina con actividad antiinflamatoria

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
HUP0104987A3 (en) 1998-12-18 2002-09-30 Axys Pharmaceuticals Inc South Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
CA2387351C (en) 1999-10-19 2009-09-08 Merck & Co., Inc. Indole derivatives as tyrosine kinase inhibitors
DK1474425T3 (da) 2002-01-07 2006-09-25 Eisai Co Ltd Deazapuriner og anvendelser deraf
MXPA05013922A (es) 2003-06-20 2006-02-24 Coley Pharm Group Inc Antagonistas de receptor tipo toll de molecula pequena.
WO2007115306A2 (en) 2006-04-04 2007-10-11 Myriad Genetics, Inc. Compounds for diseases and disorders
US20060235037A1 (en) * 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US8027888B2 (en) 2006-08-31 2011-09-27 Experian Interactive Innovation Center, Llc Online credit card prescreen systems and methods
WO2008065198A1 (en) 2006-12-01 2008-06-05 Galapagos N.V. Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
WO2008152471A1 (en) 2007-06-12 2008-12-18 Coley Pharmaceutical Group, Inc. Quinazoline derivative useful as toll-like receptor antagonist
WO2009030996A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
EP2205085A1 (en) 2007-09-25 2010-07-14 Merck Sharp & Dohme Corp. 2-aryl or heteroaryl indole derivatives
US8354400B2 (en) 2008-09-26 2013-01-15 Eisai R&D Co., Ltd. Benzoxazole compounds and methods of use
CA2738929A1 (en) 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
NO2453895T3 (https=) 2009-07-16 2018-10-20
BR112012006630A2 (pt) 2009-09-24 2016-05-03 Hoffmann La Roche derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac)
US20110098311A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorported Compositions for treatment of cystic fibrosis and other chronic diseases
WO2012054862A2 (en) 2010-10-21 2012-04-26 The Brigham And Women's Hospital, Inc. Agents, compositions, and methods for treating pruritis and related skin conditions
DK2663555T3 (en) 2011-01-12 2017-03-27 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
EP3208263A1 (en) 2011-01-12 2017-08-23 VentiRx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
WO2012167053A1 (en) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Novel immune system modulators
CA2837227C (en) 2011-06-01 2022-05-10 Janus Biotherapeutics, Inc. Novel immune system modulators
CA2836487A1 (en) 2011-06-09 2012-12-13 Rhizen Pharmaceuticals Sa Novel compounds as modulators of gpr-119
TWI567079B (zh) * 2011-07-15 2017-01-21 健生醫藥公司 作為伽瑪分泌酶調節劑之新穎的經取代的吲哚衍生物
CA2850932A1 (en) 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
JP6184423B2 (ja) 2012-05-18 2017-08-23 大日本住友製薬株式会社 カルボン酸化合物
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
SG10202103278TA (en) 2013-10-14 2021-04-29 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
EP3080124A1 (en) 2013-12-13 2016-10-19 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
HRP20210927T1 (hr) 2014-08-15 2021-09-03 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Spojevi pirolopirimidina koje se koriste kao agonist tlr7
EP3183251A4 (en) 2014-08-22 2017-12-27 Janus Biotherapeutics, Inc. Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
US10071079B2 (en) * 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
MX391344B (es) 2016-07-30 2025-03-21 Bristol Myers Squibb Co Compuestos indol sustituidos con dimetoxifenilo como inhibidores de receptores tipo toll 7, 8 o 9 (tlr7, tlr8 o tlr9).
KR102519535B1 (ko) * 2016-09-09 2023-04-06 브리스톨-마이어스 스큅 컴퍼니 피리딜 치환된 인돌 화합물

Similar Documents

Publication Publication Date Title
JP2021503004A5 (https=)
AU2019203444B2 (en) Bicyclic lactams and methods of use thereof
US11739098B2 (en) Substituted indole compounds
WO2025049746A1 (en) Compositions comprising werner syndrome helicase inhibitors and methods of using the same
JP2021506941A5 (https=)
JP2020522570A5 (https=)
BR112021001292A2 (pt) compostos heterobicíclicos para inibir a atividade de shp2
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
JP2022502424A5 (https=)
JP2014506929A5 (https=)
CA2921880A1 (en) Alkynyl alcohols and methods of use
JP2021504380A5 (https=)
JP2014528482A5 (https=)
JP2023543433A5 (https=)
JP2021512954A5 (https=)
IL233872A (en) Compounds 4 - (benzoimidazole-2-yl) -thiazole and related azo
EP4288431A1 (en) Azabicyclic shp2 inhibitors
JP2022502440A5 (https=)
KR20230107291A (ko) PPARγ 조절제 및 사용 방법
TW202334166A (zh) 螺三環ripk1抑制劑及其使用方法
WO2026006796A1 (en) Compositions comprising werner syndrome helicase inhibitors and methods of using the same
RU2021111918A (ru) Модуляторы моноацилглицерин-липазы
TW202610638A (zh) 包含維爾納症候群解旋酶抑制劑之組成物及其使用方法
CN121991061A (zh) 含杂芳基类化合物、其制备方法和应用
NZ737297B2 (en) Bicyclic lactams and methods of use thereof